These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6225331)

  • 41. Survey of genes encoding staphylococcal enterotoxins, toxic shock syndrome toxin 1, and exfoliative toxins in members of the Staphylococcus sciuri group.
    Dakić I; Vukovic D; Stepanović S; Hauschild T; Jezek P; Petrás P; Morrison D
    J Clin Microbiol; 2005 Sep; 43(9):4875-6. PubMed ID: 16145164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Frequency of toxic-shock-syndrome-toxin producing strains of Staphylococcus aureus in the Basel region].
    Vischer WA; Stalder H; Faupel DM
    Schweiz Med Wochenschr; 1985 Aug; 115(35):1196-9. PubMed ID: 4048915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production of toxic shock syndrome toxin-1 (TSST-1) by Staphylococcus aureus strains isolated from humans, animals and foods in Nigeria.
    Adesiyun AA; Lenz W; Schaal KP
    Microbiologica; 1992 Apr; 15(2):125-33. PubMed ID: 1602983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxic shock syndrome toxin-1 (TSST-1) production in staphylococcal infections and serological implications with patients and healthy controls.
    Naidu AS; Vörös S; Löczi G; Kienle Z; Brasch B; Emödy L
    Acta Microbiol Hung; 1989; 36(1):19-24. PubMed ID: 2603642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of toxin genes by polymerase chain reaction in Staphylococcus aureus strains isolated from bovine mastitis in Turkey.
    Karahan M; Açik MN; Cetinkaya B
    Foodborne Pathog Dis; 2009 Oct; 6(8):1029-35. PubMed ID: 19642915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of specific antibodies in cord blood, infant and maternal saliva and breast milk to staphylococcal toxins implicated in sudden infant death syndrome (SIDS).
    Harrison LM; Morris JA; Bishop LA; Lauder RM; Taylor CA; Telford DR
    FEMS Immunol Med Microbiol; 2004 Sep; 42(1):94-104. PubMed ID: 15325402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Staphylococcus aureus nasal carriage, virulence traits, antibiotic resistance mechanisms, and genetic lineages in healthy humans in Spain, with detection of CC398 and CC97 strains.
    Lozano C; Gómez-Sanz E; Benito D; Aspiroz C; Zarazaga M; Torres C
    Int J Med Microbiol; 2011 Aug; 301(6):500-5. PubMed ID: 21570348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotypic characterization of toxic shock syndrome toxin-1-producing strains of Staphylococcus aureus isolated in the Czech Republic.
    Hrstka R; Růzicková V; Petrás P; Pantůcek R; Rosypal S; Doskar J
    Int J Med Microbiol; 2006 Feb; 296(1):49-54. PubMed ID: 16423687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reporting of toxic shock syndrome Staphylococcus aureus in 1982 to 1990.
    Schlievert PM; Kim MH
    J Infect Dis; 1991 Dec; 164(6):1245-6. PubMed ID: 1955734
    [No Abstract]   [Full Text] [Related]  

  • 50. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease.
    Leung DY; Sullivan KE; Brown-Whitehorn TF; Fehringer AP; Allen S; Finkel TH; Washington RL; Makida R; Schlievert PM
    Pediatr Res; 1997 Sep; 42(3):268-72. PubMed ID: 9284264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A severe case of neonatal toxic shock syndrome-like exanthematous disease with superantigen-induced high T cell response.
    Miki M; Uchiyama T; Kato H; Nishida H; Takahashi N
    Pediatr Infect Dis J; 2006 Oct; 25(10):950-2. PubMed ID: 17006297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
    Bohach GA; Fast DJ; Nelson RD; Schlievert PM
    Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients.
    Park JY; Kim JS; Woo H
    Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Staphylococci associated with toxic shock syndrome in the United Kingdom.
    de Saxe MJ; Wieneke AA; de Azevedo J; Arbuthnott JP
    Ann Intern Med; 1982 Jun; 96(6 Pt 2):991-6. PubMed ID: 6212009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Staphylococcus aureus: some host-parasite interactions.
    Kapral FA
    Ann N Y Acad Sci; 1974 Jul; 236(0):267-76. PubMed ID: 4278721
    [No Abstract]   [Full Text] [Related]  

  • 56. Staphylococcal scalded skin syndrome. An ultrastructural study.
    de Dobbeleer G; Achten G
    J Cutan Pathol; 1975; 2(2):91-8. PubMed ID: 132461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Binding and Simulation Studies of Staphylococcus aureus Superantigens with Flavonoid Compounds.
    Mohan R; Venugopal S
    Infect Disord Drug Targets; 2020; 20(4):531-542. PubMed ID: 30727923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Staphylococcal enterotoxin A involvement in the illness of a 20-month-old burn patient.
    Maródi L; Káposzta R; Rozgonyi F; Bergdoll MS
    Pediatr Infect Dis J; 1995 Jul; 14(7):632-4. PubMed ID: 7567300
    [No Abstract]   [Full Text] [Related]  

  • 59. [Generalized skin change in a newborn infant: infectious, genetic or autoimmune cause? Epidermolytic ichthyosis].
    Jaeger J; Andres C; Grosber M; Suarez IL; Zirbs M; Ring J; Brockow K
    MMW Fortschr Med; 2013 Mar; 155(4):5, 72. PubMed ID: 23614180
    [No Abstract]   [Full Text] [Related]  

  • 60. Epidemiological investigation of exfoliative toxin-producing Staphylococcus aureus strains in hospitalized patients.
    Piemont Y; Rasoamananjara D; Fouace JM; Bruce T
    J Clin Microbiol; 1984 Mar; 19(3):417-20. PubMed ID: 6232283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.